Renaissance Technologies - CHECKMATE PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CHECKMATE PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2021$42,000
-70.0%
10,667
-54.6%
0.00%
Q2 2021$140,00023,5000.00%
Other shareholders
CHECKMATE PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 1,501,716$17,284,0008.25%
venBio Partners LLC 3,673,374$42,281,0006.42%
Omega Fund Management, LLC 1,335,050$15,366,0004.16%
Sofinnova Investments, Inc. 3,606,707$41,513,0003.08%
Novo Holdings A/S 2,170,100$24,978,0001.24%
CLOUGH CAPITAL PARTNERS L P 1,313,286$14,864,0001.07%
SECTORAL ASSET MANAGEMENT INC 600,687$6,914,0000.59%
CAAS CAPITAL MANAGEMENT LP 44,966$518,0000.01%
Zimmer Partners, LP 25,000$288,0000.00%
Ensign Peak Advisors, Inc 119,915$1,380,0000.00%
View complete list of CHECKMATE PHARMACEUTICALS IN shareholders